It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids ...
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
In the past two weeks, the Trump administration has spent a remarkable amount of time undoing health orders—not just the ...
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...